POSTER SESSION V
Wednesday, March 2, 2011 — 9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
PULMONARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
247
Pulmonary Neuroendocrine Carcinomas Show Alteration of Nrf2/Keap1 Pathway.
(1804)
K Shilo, W-S Chu, J Jen, W Travis, T Franks, C Hitchcock, W Zhao, R Ganju - OSU, Columbus, OH; AFIP, Washington, DC; Mayo Clinic, Rochester, MN; MSKCC, New York, NY
MASH1: A Specific Immunohistochemical Marker for High Grade Neuroendocrine Tumors of the Lung.
(1729)
J Cappel, J Findeis-Hosey, L McMahon, Q Yang, H Xu, F Li - University of Rochester Medical Center, NY
Chemokine Receptor CXCR4 Expression Correlates with Tumor Grade in Pulmonary Neuroendocrine Carcinomas.
(1766)
S Kirby, N Mohd, J Jen, W Travis, T Franks, C Hitchcock, W Zhao, R Ganju, K Shilo - The Ohio State University Medical Center, Columbus; Mayo Clinic, Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; AFIP, Washington, DC
Differential Expression of microRNA Markers in Pulmonary Neuroendocrine Tumors: Correlation with Histologic Grade.
(1798)
MS Roh, CH Lee, HK Chang, S Chang, SY Ha, KY Kwon, IS Hwang, HW Lee, EH Lee - Dong-A University, Busan, Republic of Korea; Busan National University, Republic of Korea; Kosin University, Busan, Republic of Korea; Inje University Ilsan Paik Hospital, Ilsan, Republic of Korea; Gachon University of Medicine and Science, Incheon, Republic of Korea; Keimyung University, Daegu, Republic of Korea; Samsung Changwon Medical Center, Changwon, Republic of Korea
IMP-3 and Ki-67 Expression in Neuroendocrine Tumors of the Lung.
(1833)
L Zhao, A Fraire, P Cagle, T Allen, K Rock, D Kandil - University of Massachusetts Medical School, Worcester; The Methodist Hospital, Houston, TX; University of Texas, Tyler
Limited Role of Ki67 Proliferative Index in Predicting Overall Survival in Patients with Pulmonary Carcinoid Tumors.
(1816)
AE Walts, C Bresee, D Ines, AM Marchevsky - Cedars-Sinai Medical Center, Los Angeles, CA
Inconsistent Findings of PET-CT Imaging in Identifying Malignancy in Cytology or Biopsy Proven Small Cell Carcinoma: A 3 Year Experience in 54 Cases.
(1733)
LM Dang, LK Green - Baylor College of Medicine, Houston, TX; DTCL and Laboratory Medicine, Houston, TX
Histologic Classification of Thymic Epithelial Tumors Differs from Classification by Grade and Stage: A Study of 138 Surgically Resected Thymomas and Thymic Carcinomas.
(1811)
WD Travis, J Huang, N Girard, DS Klimstra, GJ Riely - Memorial Sloan Kettering Cancer Center, New York, NY
Temporal Evolution of Histologic and Cell-Kinetic Parameters of Recurrent and Metastatic Thymic Neoplasms.
(1797)
AC Roden, ES Yi, JL Donovan, SD Cassivi, YI Garces, RS Marks, MC Aubry - Mayo Clinic, Rochester
Detection of NUT Midline Carcinoma in Retrospective Analysis of Thymic and Mediastinal Neoplasms.
(1739)
A Evans, C Fletcher, C French, D Jackman, C Lathan, L Sholl - Brigham and Women's Hospital, Boston, MA; Dana Farber Cancer Institute, Boston, MA
Differentiation of NUT Midline Carcinoma in Humans and Mice by Epigenomic Reprogramming.
(1801)
B Schwartz, M Hofer, M Lemieux, D Bauer, M Cameron, N West, E Agoston, T Ince, K Janeway, S Vargas, A Perez-Atayde, J Aster, S Sallan, A Kung, J Bradner, C French - Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute, Boston, MA; Children's Hospital, Boston, MA
Increased Expression of Collagen V and IL-17 during Usual Interstitial Pneumonia.
(1829)
C Zhang, DS Wilkes, OW Cummings - Indiana University, Indianapolis
Higher Metabolic Activity in Fibroblastic Foci of UIP Than in Buds of Fibrosis in Intra-Alveolar Buds in COP/BOOP.
(1778)
O Matsubara, K Kobayashi, S Yamamoto, R Kikuchi, K Iwaya, Y Nakatani, RL Kradin, EJ Mark - National Defense Medical College, Tokorozawa, Saitama, Japan; Chiba University, Japan; Massachusetts General Hospital and Harvard Medical School, Boston
Histoarchitecture and Biochemical Profile of Collagen V in Skin and Lung Fibroblasts Culture from Patients with SSc Indicate a Defect in Fibrilogenesis.
(1809)
WR Teodoro, APP Velosa, RBC Souza, S Carrasco, J de Morais, P Martin, ER Parra, NH Yoshinari, VL Capelozzi - Faculdade de Medicina da Universidade de Sao Paulo, Brazil
Different Cytokines and Growth Factors Have Different Expression in Limited or Diffuse Systemic Sclerosis.
(1792)
ER Parra, LO Silva, M Rangel, SM Fernezlian, VL Capelozzi - Faculdade de Medicina da Universidade de Sao Paulo, Brazil
Increase of EZH2 Expression in Bronchiolar Epithelial Cells in Smoking-Related Diseases of the Lung.
(1740)
JJ Findeis-Hosey, LA McMahon, Q Yang, F Li, H Xu - University of Rochester, NY
Pathological and Radiographic Evaluation of Asbestos Exposure.
(1820)
D Wu, K Hiroshima, F Sakai, T Kishimoto, T Yusa, K Onishi, I Usami, T Morikawa - Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan; Saitama Medical University, Hidaka, Japan; Okayama Rosai Hospital, Japan; Chiba Rosai Hospital, Ichihara, Japan; Kobe Rosai Hospital, Japan; Asahi Rosai Hospital, Owari Asahi, Japan; Yokohama Rosai Hospital, Japan
Expression of Melanocyte Differentiation Markers in Pulmonary Lymphangioleiomyomatosis Offers Potential for Immunotheraputic Targeting.
(1767)
J Klarquist, R Boissy, MM Picken, R Love, C Le Poole - Loyola University Medical Center, Maywood, IL
Variant Pulmonary Alveolar Proteinosis: A Syndrome with Distinct Clinical and Pathologic Features.
(1786)
M Nishino, EJ Mark, O Matsubara, BD Medoff, WJ O'Donnell, PF Currier, RL Kradin - Massachusetts General Hospital, Boston; National Defense Medical College, Tokorozawa, Saitama, Japan
A Novel Computer Image Analysis Algorithm Improves Inter-Rater Reliability in the Evaluation of Respiratory Mucosal Ciliary Ultrastructure.
(1745)
K Funkhouser, M Neithammer, J Carson, B Baker, S Minnix, M Leigh, M Knowles, W Funkhouser - UNC, Chapel Hill, NC
Pleuropulmonary Infection by Paragonimus westermani in the United States: A Clinicopathologic Analysis of Four Cases with Identification of a Unique Risk Factor.
(1724)
JM Boland, LT Vaszar, JL Jones, P Wilkins, MA Rovzar, TV Colby, KO Leslie, HD Tazelaar - Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AZ; Centers for Disease Control and Prevention, Atlanta, GA; Mission Regional Medical Center, Mission Viejo, CA
Causes of Granulomatous Inflammation in Lung Biopsies and Resections from Diverse Geographic Settings: An International, Multi-Institution Retrospective Study of 500 Cases.
(1783)
S Mukhopadhyay, C Farver, LT Vaszar, OJ Dempsey, HH Popper, H Mani, VL Capelozzi, J Fukuoka, KM Kerr, EH Zeren, VK Iyer, T Tanaka, I Narde, A Nomikos, D Gumurdulu, S Arava, DS Zander, HD Tazelaar - State University of New York Upstate Medical University, Syracuse; Cleveland Clinic, OH; Mayo Clinic, Scottsdale, AZ; Aberdeen University Medical School, United Kingdom; Medical University of Graz, Austria; Penn State Milton S. Hershey Medical Center, Hershey, PA; University of Sao Paulo, Brazil; Toyama University Hospital, Japan; Cukurova University, Adana, Turkey; All India Institute of Medical Sciences, New Delhi, India; Acibadem Health Group, Istanbul, Turkey
Transbronchial Lung Biopsy Is Not an Optimal Method for Evaluating Chronic Rejection in Lung Transplant Patients.
(1775)
Y Li, Z Hu, J Gagermeier, MM Picken - Loyola University Medical Center, Maywood, IL; Loyola Unversity Medical Center, Maywood, IL
Histological Spectrum of Pulmonary Manifestations in Kidney Transplant Recipients.
(1765)
S Kirby, A Satoskar, S Brodsky, A Pope-Harman, D Nunley, C Hitchcock, R Pelletier, T Nadasdy, K Shilo - The Ohio State University, Columbus
Proteomic Analysis of the Lung in Rats with Hypobaric Hypoxia-Induced Pulmonary Hypertension.
(1790)
Y Ohata, S Ogata, K Nakanishi, S Hiroi, S Tominaga, T Kawai - National Defense Medical College, Tokorozawa, Saitama, Japan
Pulmonary Hypertension in Cirrhosis, Study of 22 Autopsy Cases.
(1725)
N Boroumand, G White, E Gregonis, A Duarte, A Haque - University of Texas Medical Branch, Galveston; Methodist Hospital, Houston
Pulmonary Arterial Remodeling in End-Stage Liver Disease.
(1743)
GA Fishbein, T Wang, R Saggar, R Saggar, M Hansen, MC Fishbein - David Geffen School of Medicine at UCLA, Los Angeles, CA
button next to any title to add to Itinerary Planner...
Add
